Citadel Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $349M | Buy |
2,733,500
+83,500
| +3% | +$10.4M | 0.06% | 266 |
|
|
2025
Q4 | $323M | Sell |
2,650,000
-1,265,200
| -32% | -$145M | 0.05% | 315 |
|
|
2025
Q3 | $392M | Buy |
3,915,200
+1,790,100
| +84% | +$161M | 0.06% | 252 |
|
|
2025
Q2 | $176M | Sell |
2,125,100
-116,900
| -5% | -$9.33M | 0.03% | 463 |
|
|
2025
Q1 | $182M | Sell |
2,242,000
-778,800
| -26% | -$69.6M | 0.03% | 402 |
|
|
2024
Q4 | $272M | Buy |
3,020,800
+745,100
| +33% | +$72.2M | 0.05% | 290 |
|
|
2024
Q3 | $225M | Sell |
2,275,700
-1,248,200
| -35% | -$123M | 0.04% | 333 |
|
|
2024
Q2 | $327M | Buy |
3,523,900
+655,900
| +23% | +$58.8M | 0.07% | 221 |
|
|
2024
Q1 | $272M | Sell |
2,868,000
-173,200
| -6% | -$16.1M | 0.05% | 271 |
|
|
2023
Q4 | $272M | Buy |
3,041,200
+466,700
| +18% | +$34.7M | 0.05% | 245 |
|
|
2023
Q3 | $188M | Buy |
2,574,500
+263,400
| +11% | +$21M | 0.04% | 335 |
|
|
2023
Q2 | $192M | Sell |
2,311,100
-484,600
| -17% | -$40.5M | 0.04% | 340 |
|
|
2023
Q1 | $213M | Sell |
2,795,700
-171,900
| -6% | -$14.3M | 0.05% | 291 |
|
|
2022
Q4 | $246M | Buy |
2,967,600
+128,200
| +5% | +$10.4M | 0.06% | 268 |
|
|
2022
Q3 | $225M | Sell |
2,839,400
-622,700
| -18% | -$52.5M | 0.05% | 271 |
|
|
2022
Q2 | $257M | Buy |
3,462,100
+302,300
| +10% | +$22.7M | 0.07% | 214 |
|
|
2022
Q1 | $284M | Sell |
3,159,800
-344,700
| -10% | -$31.8M | 0.06% | 227 |
|
|
2021
Q4 | $392M | Buy |
3,504,500
+2,327,500
| +198% | +$281M | 0.08% | 156 |
|
|
2021
Q3 | $148M | Sell |
1,177,000
-128,400
| -10% | -$16.5M | 0.03% | 467 |
|
|
2021
Q2 | $177M | Buy |
1,305,400
+242,600
| +23% | +$31.9M | 0.04% | 368 |
|
|
2021
Q1 | $144M | Buy |
1,062,800
+72,100
| +7% | +$10.8M | 0.04% | 422 |
|
|
2020
Q4 | $139M | Sell |
990,700
-426,600
| -30% | -$54.6M | 0.04% | 394 |
|
|
2020
Q3 | $158M | Sell |
1,417,300
-307,100
| -18% | -$34.4M | 0.04% | 270 |
|
|
2020
Q2 | $193M | Sell |
1,724,400
-326,500
| -16% | -$32.2M | 0.07% | 192 |
|
|
2020
Q1 | $159M | Buy |
2,050,900
+159,800
| +8% | +$14.2M | 0.07% | 191 |
|
|
2019
Q4 | $180M | Buy |
1,891,100
+577,900
| +44% | +$50M | 0.08% | 195 |
|
|
2019
Q3 | $100M | Sell |
1,313,200
-448,000
| -25% | -$37.2M | 0.05% | 400 |
|
|
2019
Q2 | $154M | Sell |
1,761,200
-686,700
| -28% | -$58.6M | 0.07% | 236 |
|
|
2019
Q1 | $222M | Buy |
2,447,900
+140,100
| +6% | +$11.9M | 0.11% | 129 |
|
|
2018
Q4 | $166M | Buy |
2,307,800
+1,458,300
| +172% | +$117M | 0.09% | 168 |
|
|
2018
Q3 | $81.4M | Sell |
849,500
-169,300
| -17% | -$16.4M | 0.04% | 498 |
|
|
2018
Q2 | $97M | Buy |
1,018,800
+203,900
| +25% | +$18.7M | 0.05% | 386 |
|
|
2018
Q1 | $71.5M | Buy |
814,900
+198,000
| +32% | +$18.1M | 0.04% | 436 |
|
|
2017
Q4 | $52.4M | Buy |
616,900
+27,500
| +5% | +$2.3M | 0.03% | 591 |
|
|
2017
Q3 | $51M | Sell |
589,400
-127,200
| -18% | -$10.2M | 0.04% | 538 |
|
|
2017
Q2 | $55.3M | Buy |
716,600
+163,700
| +30% | +$11.6M | 0.05% | 457 |
|
|
2017
Q1 | $38.3M | Sell |
552,900
-172,200
| -24% | -$11.6M | 0.04% | 578 |
|
|
2016
Q4 | $42.9M | Sell |
725,100
-176,800
| -20% | -$10.9M | 0.04% | 445 |
|
|
2016
Q3 | $59.8M | Buy |
+901,900
| New | +$55.8M | 0.06% | 315 |
|
Other funds holding XBI
